Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Ocul Immunol Inflamm. 2017 Oct 16;27(3):349–355. doi: 10.1080/09273948.2017.1367406

Table 2.

Prevalence of cystoid macular edema (CME) in eyes with peripheral vascular leakage as a function of whether treatment augmentation occurred.

CME
n Initial visit Intermediate visit Final visit
Treatment augmentation 27 13 (48%) 5 (19%) 2 (7%)
No Treatment Augmentation 14 2 (14%) 2 (14%) 1 (7%)
p-value 0.03a 0.79b 0.92b
a

Statistically significant at alpha=0.05

b

P-values calculated after adjusting for baseline presence of CME